COLON CARCINOMA IN RENAL TRANSPLANT RECIPIENT- CASE REPORT

Renal transplant recipients are prone to infectious, metabolic and neoplastic complications, which is the trade off for low incidence of rejection with potent immunosuppressive drugs. Malignancy is the third common cause of death after transplantation. Normal immunological surveillance is impaired in transplant recipients due to the immunosuppressive drugs. Our patient was a 50 year lady, who had normal graft function until 9 years post transplant, presented with disseminated colon carcinoma.